TOXICOLOGICAL PROFILE FOR CHROMIUM - Davidborowski.com
TOXICOLOGICAL PROFILE FOR CHROMIUM - Davidborowski.com TOXICOLOGICAL PROFILE FOR CHROMIUM - Davidborowski.com
CHROMIUM 1002. HEALTH EFFECTSspermatocytes (high dose, intermediate dose) and stage-7 spermatid (high and intermediate doses) countswere significantly reduced and were treatment related. Testicular activity of succinic dehydrogenase wassignificantly lowered in the two high-dose groups, testicular cholesterol concentrations were elevated inthe highest-dosed group, and both serum testosterone and testicular levels of 3β-∆ 5 -hydroxysteroiddehydrogenase were significantly lowered. The authors also determined that the total testicular levels ofascorbic acid in the two higher-dosing groups was about twice that of the control values whereas, in thehighest-treated group the total ascorbic acid levels were about half those of controls. At the low dose(20 mg/kg/day), testicular protein, 3β-∆ 5 -hydroxysteroid dehydrogenase, and serum testosterone weredecreased. The authors indicated that chromium enhanced levels of the vitamin, but at the highest dosetesticular levels became exhausted, thus decreasing the ability of the cells to reduce chromium(VI).Significant alterations in sexual behavior and aggressive behavior were observed in male Sprague-Dawleyrats exposed to 42 mg chromium(VI)/kg/day as potassium dichromate in the drinking water for 12 weeks(Bataineh et al. 1997). The alterations in sexual behavior included decreased number of mounts, lowerpercentage of ejaculating males, and increased ejaculatory latency and post-ejaculatory interval. Theadverse effects on aggressive behavior included significant decreases in the number of lateralizations,boxing bouts, and fights with the stud male and ventral presenting. No significant alterations in fertilitywere observed when the exposed males were mated with unexposed females.Mice exposed for 7 weeks to 15.2 mg chromium(VI)/kg/day as potassium dichromate in the diet hadreduced sperm count and degeneration of the outer cellular layer of the seminiferous tubules.Morphologically altered sperm occurred in mice given diets providing 28 mg chromium(VI)/kg/day aspotassium dichromate (Zahid et al. 1990). No effect was found on testis or epididymis weight, andreproduction function was not assessed. In contrast, an increase in testes weight was observed in miceexposed to 6 mg chromium(VI)/kg/day as potassium dichromate for 12 weeks. At the next highest dose(14 mg chromium(VI)/kg/day), decreases in seminal vesicle and preputial gland weights were observed(Elbetieha and Al-Hamood 1997). In studies designed to confirm or refute the findings of the Zahid et al.(1990) study, the reproductive effects of different concentrations of chromium(VI) as potassiumdichromate in the diet on BALB/c mice and Sprague-Dawley rats were investigated (NTP 1996a, 1996b).Groups of 24 males and 48 females of each species were fed potassium dichromate(VI) in their feedcontinuously for 9 weeks followed by an 8-week recovery period. For mice, the average daily ingestionsof chromium(VI) were 1.05, 3.5, 7.5, and 32.2 mg/kg/day for males and 1.8, 5.7, 12.0, and 48 mg/kg/dayfor females. For rats, the average daily ingestions of chromium(VI) were 0.35, 1.05, 2.1, and8.4 mg/kg/day for males and 0.35, 1.05, 2.45, and 9.8 mg/kg/day for females (NTP 1996b). Microscopic
CHROMIUM 1012. HEALTH EFFECTSexaminations of the ovaries showed no treatment-related effects, and examination of the testes andepididymis for Sertoli nuclei and preleptotene spermatocyte counts in stage X or XI tubules did not revealany treatment-related effects.Murthy et al. (1996) reported a number of reproductive effects in female Swiss albino mice exposed topotassium dichromate in drinking water for 20 days. The observed effects included a significantreduction in the number of follicles at different stages of maturation at $60 mg chromium(VI)/kg/day,reduction in the number of ova/mice at $120 mg chromium(VI)/kg/day, significant increase in estruscycle duration at 180 mg chromium(VI)/kg/day, and histological alterations in the ovaries (e.g.,proliferated, dilated, and congested blood vessels, pyknotic nuclei in follicular cells, and atretic follicles)at $120 mg chromium(VI)/kg/day. The severity of the reproductive effects appeared to be dose-related.In an ancillary study, electron microscopy of selected ovarian tissues revealed ultrastructural changes(disintegrated cell membranes of two-layered follicular cells and altered villiform cristae of mitochondriaand decreased lipid droplets in interstitial cells) in mice exposed to 1.2 mg chromium(VI)/kg/day for90 days; the toxicological significance of these alterations is not known. The study authors suggest thatthe effects observed in the interstitial cells may be due to a reduction in lipid synthesizing ability, whichcould lead to decreased steroid hormone production. An increase in relative ovarian weight was observedin female mice exposed for 12 weeks to 14 mg chromium(VI)/kg/day as potassium dichromate (Elbetiehaand Al-Hamood 1997).Several studies have reported increases in preimplantation losses and resorptions in rats and mice exposedto chromium(VI). Exposure of pregnant mice to 46 mg chromium(VI)/kg/day as potassium dichromate indrinking water during gestation resulted in increased preimplantation and postimplantation loss, anddecreased litter size. Maternal body weight gain decreased at doses $98 mg chromium(VI)/kg/day(Trivedi et al. 1989). In female Swiss albino mice exposed for 20 days prior to mating to potassiumdichromate in drinking water at concentrations that resulted in doses of 0, 52, 98, or 169 mgchromium(VI)/kg/day and then mated, the number of corpora lutea was decreased at 169 mg/kg/day,preimplantation loss and resorptions were increased at $98 mg/kg/day, and placental weights weredecreased at $57 mg/kg/day (Junaid et al. 1996a). Increases in the number of resorptions were also foundin female Swiss albino rats exposed to 37, 70, or 87 mg chromium(VI)/kg/day (as potassium dichromatein the drinking water) for 20 days prior to mating (Kanojia et al. 1996). Additional reproductive effectsobserved at 70 or 87 mg chromium(VI)/kg/day include decreased number of corpora lutea, decreasednumber of implantations, and increased number of pre-implanation losses. A treatment-related increase inthe length of estrus cycle was significantly different from controls only in the 87 mg
- Page 70 and 71: CHROMIUM 502. HEALTH EFFECTSChromiu
- Page 72 and 73: CHROMIUM 522. HEALTH EFFECTSAn exte
- Page 74 and 75: CHROMIUM 542. HEALTH EFFECTS2.2.1.7
- Page 76 and 77: CHROMIUM 562. HEALTH EFFECTS2.2.1.8
- Page 78 and 79: CHROMIUM 582. HEALTH EFFECTSmajor p
- Page 80 and 81: CHROMIUM 602. HEALTH EFFECTSfound a
- Page 82 and 83: CHROMIUM 622. HEALTH EFFECTSsignifi
- Page 84 and 85: CHROMIUM 642. HEALTH EFFECTSheavy s
- Page 86 and 87: CHROMIUM 662. HEALTH EFFECTScarcino
- Page 88 and 89: CHROMIUM 682. HEALTH EFFECTS(female
- Page 90 and 91: CHROMIUM 702. HEALTH EFFECTSFerroch
- Page 92 and 93: CHROMIUM 722. HEALTH EFFECTS1.2x10
- Page 94 and 95: CHROMIUM 742. HEALTH EFFECTSchromiu
- Page 96 and 97: 8 Rat once 26 M (LD 50)(Fischer- 34
- Page 98 and 99: 20 Mouse 9 d Bd Wt 53.2 F 101 .1 F
- Page 100 and 101: 32 Rat(BD)33 RatSwiss albino34 RatD
- Page 102 and 103: Neurological45 Rat 28 d(Wistar)Repr
- Page 104 and 105: 59 Mouse 85 d + 36.7 F NTP 1997(BAL
- Page 106 and 107: CHRONIC EXPOSURESystemic70 Human71
- Page 108 and 109: Figure 2-2. Levels of Significant E
- Page 110 and 111: MinimalFigure 2-2. Levels of Signif
- Page 112 and 113: CHROMIUM 922. HEALTH EFFECTSand blo
- Page 114 and 115: CHROMIUM 942. HEALTH EFFECTSHematol
- Page 116 and 117: CHROMIUM 962. HEALTH EFFECTSAverage
- Page 118 and 119: CHROMIUM 982. HEALTH EFFECTSchanges
- Page 122 and 123: CHROMIUM 1022. HEALTH EFFECTSchromi
- Page 124 and 125: CHROMIUM 1042. HEALTH EFFECTS2.2.2.
- Page 126 and 127: CHROMIUM 1062. HEALTH EFFECTSImpair
- Page 128 and 129: CHROMIUM 1082. HEALTH EFFECTSrates
- Page 130 and 131: TABLE 2-3. Levels of Significant Ex
- Page 132 and 133: HumanHumanHumanHumanHumanHumanHuman
- Page 134 and 135: CHRONIC EXPOSURESystemicHuman 7.5 y
- Page 136 and 137: CHROMIUM 1162. HEALTH EFFECTSNo stu
- Page 138 and 139: CHROMIUM 1182. HEALTH EFFECTSIrrita
- Page 140 and 141: CHROMIUM 1202. HEALTH EFFECTSindust
- Page 142 and 143: CHROMIUM 1222. HEALTH EFFECTSGuinea
- Page 144 and 145: CHROMIUM 1242. HEALTH EFFECTSmodel,
- Page 146 and 147: CHROMIUM 1262. HEALTH EFFECTSblood,
- Page 148 and 149: CHROMIUM 1282. HEALTH EFFECTSchromi
- Page 150 and 151: CHROMIUM 1302. HEALTH EFFECTSAlthou
- Page 152 and 153: CHROMIUM 1322. HEALTH EFFECTS2.3.2
- Page 154 and 155: CHROMIUM 1342. HEALTH EFFECTS2.3.2.
- Page 156 and 157: CHROMIUM 1362. HEALTH EFFECTSThe di
- Page 158 and 159: CHROMIUM 1382. HEALTH EFFECTS(2-5 m
- Page 160 and 161: CHROMIUM 1402. HEALTH EFFECTSIn rat
- Page 162 and 163: CHROMIUM 1422. HEALTH EFFECTSunstab
- Page 164 and 165: CHROMIUM 1442. HEALTH EFFECTSIn add
- Page 166 and 167: CHROMIUM 1462. HEALTH EFFECTSsignif
- Page 168 and 169: CHROMIUM 1482. HEALTH EFFECTS2.3.4.
<strong>CHROMIUM</strong> 1002. HEALTH EFFECTSspermatocytes (high dose, intermediate dose) and stage-7 spermatid (high and intermediate doses) countswere significantly reduced and were treatment related. Testicular activity of succinic dehydrogenase wassignificantly lowered in the two high-dose groups, testicular cholesterol concentrations were elevated inthe highest-dosed group, and both serum testosterone and testicular levels of 3β-∆ 5 -hydroxysteroiddehydrogenase were significantly lowered. The authors also determined that the total testicular levels ofascorbic acid in the two higher-dosing groups was about twice that of the control values whereas, in thehighest-treated group the total ascorbic acid levels were about half those of controls. At the low dose(20 mg/kg/day), testicular protein, 3β-∆ 5 -hydroxysteroid dehydrogenase, and serum testosterone weredecreased. The authors indicated that chromium enhanced levels of the vitamin, but at the highest dosetesticular levels became exhausted, thus decreasing the ability of the cells to reduce chromium(VI).Significant alterations in sexual behavior and aggressive behavior were observed in male Sprague-Dawleyrats exposed to 42 mg chromium(VI)/kg/day as potassium dichromate in the drinking water for 12 weeks(Bataineh et al. 1997). The alterations in sexual behavior included decreased number of mounts, lowerpercentage of ejaculating males, and increased ejaculatory latency and post-ejaculatory interval. Theadverse effects on aggressive behavior included significant decreases in the number of lateralizations,boxing bouts, and fights with the stud male and ventral presenting. No significant alterations in fertilitywere observed when the exposed males were mated with unexposed females.Mice exposed for 7 weeks to 15.2 mg chromium(VI)/kg/day as potassium dichromate in the diet hadreduced sperm count and degeneration of the outer cellular layer of the seminiferous tubules.Morphologically altered sperm occurred in mice given diets providing 28 mg chromium(VI)/kg/day aspotassium dichromate (Zahid et al. 1990). No effect was found on testis or epididymis weight, andreproduction function was not assessed. In contrast, an increase in testes weight was observed in miceexposed to 6 mg chromium(VI)/kg/day as potassium dichromate for 12 weeks. At the next highest dose(14 mg chromium(VI)/kg/day), decreases in seminal vesicle and preputial gland weights were observed(Elbetieha and Al-Hamood 1997). In studies designed to confirm or refute the findings of the Zahid et al.(1990) study, the reproductive effects of different concentrations of chromium(VI) as potassiumdichromate in the diet on BALB/c mice and Sprague-Dawley rats were investigated (NTP 1996a, 1996b).Groups of 24 males and 48 females of each species were fed potassium dichromate(VI) in their feedcontinuously for 9 weeks followed by an 8-week recovery period. For mice, the average daily ingestionsof chromium(VI) were 1.05, 3.5, 7.5, and 32.2 mg/kg/day for males and 1.8, 5.7, 12.0, and 48 mg/kg/dayfor females. For rats, the average daily ingestions of chromium(VI) were 0.35, 1.05, 2.1, and8.4 mg/kg/day for males and 0.35, 1.05, 2.45, and 9.8 mg/kg/day for females (NTP 1996b). Microscopic